| UniProt ID | CHRC1_HUMAN | |
|---|---|---|
| UniProt AC | Q9NRG0 | |
| Protein Name | Chromatin accessibility complex protein 1 | |
| Gene Name | CHRAC1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 131 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Forms a complex with DNA polymerase epsilon subunit POLE3 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome remodeling activity of ISWI/SNF2H and ACF1.. | |
| Protein Sequence | MADVVVGKDKGGEQRLISLPLSRIRVIMKSSPEVSSINQEALVLTAKATELFVQCLATYSYRHGSGKEKKVLTYSDLANTAQQSETFQFLADILPKKILASKYLKMLKEEKREEDEENDNDNESDHDEADS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MADVVVGKD ------CCCEEEECC | 20.50 | 22814378 | |
| 8 | Acetylation | MADVVVGKDKGGEQR CCCEEEECCCCCCEE | 44.66 | 23749302 | |
| 8 | Ubiquitination | MADVVVGKDKGGEQR CCCEEEECCCCCCEE | 44.66 | 33845483 | |
| 60 | Phosphorylation | VQCLATYSYRHGSGK HHHHHHCHHHCCCCC | 16.01 | 24719451 | |
| 67 | Acetylation | SYRHGSGKEKKVLTY HHHCCCCCEEEEEEH | 68.97 | 156597 | |
| 102 | 2-Hydroxyisobutyrylation | PKKILASKYLKMLKE CHHHHHHHHHHHHHH | 49.33 | - | |
| 102 | Acetylation | PKKILASKYLKMLKE CHHHHHHHHHHHHHH | 49.33 | 19608861 | |
| 102 | Ubiquitination | PKKILASKYLKMLKE CHHHHHHHHHHHHHH | 49.33 | 33845483 | |
| 105 | "N6,N6-dimethyllysine" | ILASKYLKMLKEEKR HHHHHHHHHHHHHHH | 38.81 | - | |
| 105 | Methylation | ILASKYLKMLKEEKR HHHHHHHHHHHHHHH | 38.81 | 23644510 | |
| 108 | "N6,N6-dimethyllysine" | SKYLKMLKEEKREED HHHHHHHHHHHHHHH | 61.40 | - | |
| 108 | Methylation | SKYLKMLKEEKREED HHHHHHHHHHHHHHH | 61.40 | 23644510 | |
| 124 | Phosphorylation | ENDNDNESDHDEADS CCCCCCCCCCCCCCC | 46.64 | 22167270 | |
| 131 | Phosphorylation | SDHDEADS------- CCCCCCCC------- | 49.52 | 22167270 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CHRC1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CHRC1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHRC1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| BAZ1A_HUMAN | BAZ1A | physical | 14759371 | |
| SMCA5_HUMAN | SMARCA5 | physical | 14759371 | |
| A4_HUMAN | APP | physical | 21832049 | |
| SMCA5_HUMAN | SMARCA5 | physical | 22939629 | |
| XPC_HUMAN | XPC | physical | 22939629 | |
| RPC9_HUMAN | CRCP | physical | 22939629 | |
| IN80C_HUMAN | INO80C | physical | 22939629 | |
| PURA2_HUMAN | ADSS | physical | 22863883 | |
| CUTA_HUMAN | CUTA | physical | 22863883 | |
| AATC_HUMAN | GOT1 | physical | 22863883 | |
| MTAP_HUMAN | MTAP | physical | 22863883 | |
| NDKA_HUMAN | NME1 | physical | 22863883 | |
| PTN11_HUMAN | PTPN11 | physical | 22863883 | |
| RBBP7_HUMAN | RBBP7 | physical | 22863883 | |
| TALDO_HUMAN | TALDO1 | physical | 22863883 | |
| FAM9B_HUMAN | FAM9B | physical | 25416956 | |
| DPOE3_HUMAN | POLE3 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-102, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124, AND MASSSPECTROMETRY. | |